Key result
The HeartLander mobile robotic device demonstrated successful prehension, locomotion, and myocardial injection on beating-heart porcine models, illustrating the feasibility of intrapericardial therapy.
A miniature mobile robotic device (HeartLander) demonstrated feasibility for navigation and intrapericardial intervention on beating-heart porcine models, potentially enabling outpatient minimally invasive cardiac surgery.
Answers are grounded in this paper and cite their sources.
Supports further robotic device development for cardiac therapy; leaves open translation from porcine models to patients.
This article describes the development and preliminary testing of a mobile robotic device to facilitate minimally invasive beating-heart intrapericardial intervention. The HeartLander robot will be introduced beneath the pericardium via subxiphoid incision, adhere to the epicardium, navigate to any location, and administer therapy under the control of the physician. As compared to current robotic cardiac surgical techniques, this novel paradigm obviates immobilization of the heart and eliminates access limitations. Furthermore, it does not require lung deflation and differential ventilation and thus could enable outpatient cardiac surgery. The current HeartLander prototypes use suction to maintain prehension of the epicardium and wire actuation to perform locomotion. A fiber optic videoscope displays visual feedback to the physician, who controls the device through a joystick interface. The initial prototype demonstrated successful prehension, turning, and locomotion on open-chest, beating-heart porcine models where the pericardium was removed (N = 3). A smaller second-generation prototype with an injection system demonstrated locomotion and myocardial injection of dye, both performed with the pericardium intact (N = 3). These trials illustrate the feasibility of using a miniature mobile robot to navigate upon the beating heart and perform intrapericardial therapy.
No takes yet. Share an insight, caveat, or question.
Patronik et al. (2005) studied Minimally invasive beating-heart intrapericardial intervention (animal model) (n=6). HeartLander mobile robotic device was evaluated on Feasibility of prehension, turning, locomotion, and myocardial injection. The HeartLander mobile robotic device demonstrated successful prehension, locomotion, and myocardial injection on beating-heart porcine models, illustrating the feasibility of intrapericardial therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: